Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: Tim Luke who wrote (69815)	11/3/1999 10:14:00 AM
From: booray	Read Replies (1) \| Respond to of 90042

This could be a momo play that has not moved much yet.... biz.yahoo.com <EDIT> for the record i am in at 3 5/16

To: Tim Luke who wrote (69815)	11/3/1999 10:45:00 AM
From: QuietWon	Respond to of 90042

NMRX's main competitor (BellSoWrls & Ardis fail on price) is Aeris, but : 1. Aeris' system requires capture of the voice channel as well as data -- uses up more of the bndwdth/spectrum, therefore fewer users on the system or less data can be xfr'd 2. Aeris' coverage (cvg) less b/c uses more power b/c must use some power for voice 3. Aeris' cvg lesser again b/c has fewer contracts with cell companies ie. smaller footprint to begin with, so if major national customer comes along, they Aeris' can't handle it NMRX's Cellemtry is the reverse ie. positive of all the above